⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATOS News
Atossa Therapeutics, Inc. Common Stock
Atos Named ‘Best in Class’ in Multiple Categories Across the 2026 PAC RADAR Evaluation of SAP Service Providers
globenewswire.com
ATOS
AI in Energy Market Projected to Reach USD 22.2 Billion by 2033, AI Adoption Across Utilities and Renewable Energy Systems Fuels Strong Market Growth
prnewswire.com
GE
AI
ATOS
FLEX
Atos joins CrowdStrike’s Project QuiltWorks to advance sovereign AI adoption and secure frontier AI risk
globenewswire.com
ATOS
CRWD
Eviden and Hexadrone combine their expertise to equip modular drones with SIGINT capabilities
globenewswire.com
ATOS
Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds
prnewswire.com
ATOS
Form 8-K
sec.gov
ATOS
Atossa Therapeutics Announces Registered Direct Offering of up to $16.5 Million in Gross Proceeds
prnewswire.com
ATOS
Qevlar vereint SOC und Vulnerability Management mit neuen KI-Agenten und verkleinert so die Angriffsfläche
businesswire.com
ATOS
Atossa Therapeutics Announces ASCO 2026 Abstracts Highlighting (Z)-Endoxifen Activity Across ESR1 Mutations and Ongoing EVANGELINE Phase 2 Trial
prnewswire.com
ATOS
Atossa Therapeutics Announces Acceptance of Manuscript Highlighting Utrophin-Modulation Potential of (Z)-Endoxifen in Duchenne Muscular Dystrophy
prnewswire.com
ATOS